| |
| |
|
| Insider
Information: |
Hambleton Julie |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
91,459 |
|
|
Indirect Shares
|
1,764 |
|
|
| Direct
Value |
$3,222,818 |
|
|
|
Indirect Value
|
$67,032 |
|
|
| Total
Shares |
93,223 |
|
|
| Total
Value |
$3,289,850 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Five Prime Therapeutics Inc |
FPRX |
EVP & Chief Medical Of... |
2015-11-11 |
84,811 |
2015-11-11 |
1,764 |
Premium* |
|
|
Igm Biosciences, Inc. |
IGMS |
Director |
2021-08-09 |
2,000 |
2019-09-18 |
0 |
Premium* |
|
|
Springworks Therapeutics, Inc. |
SWTX |
Director |
2023-07-19 |
4,648 |
2021-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2023-07-19 |
4 |
AS |
$29.31 |
$70,876 |
D/D |
(2,418) |
4,648 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2023-06-20 |
4 |
AS |
$26.92 |
$64,603 |
D/D |
(2,400) |
7,066 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,648 |
9,466 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2023-03-15 |
4 |
S |
$31.50 |
$34,841 |
D/D |
(1,106) |
4,818 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,818 |
5,924 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2021-08-09 |
4 |
AS |
$80.00 |
$80,000 |
D/D |
(1,000) |
2,000 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2021-06-01 |
4 |
AS |
$80.00 |
$160,000 |
D/D |
(2,000) |
3,000 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,106 |
5,995 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2019-09-18 |
4 |
B |
$18.31 |
$91,550 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP & Chief Medical Officer |
• – – |
2015-11-11 |
4 |
S |
$34.33 |
$800,238 |
D/D |
(23,108) |
84,811 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP & Chief Medical Officer |
• – – |
2015-11-11 |
4 |
OE |
$7.26 |
$206,280 |
D/D |
22,000 |
97,919 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP & Chief Medical Officer |
• – – |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
85,740 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
SVP & Chief Medical Officer |
• – – |
2015-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,980 |
9,979 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP & Chief Medical Officer |
• – – |
2014-08-22 |
4 |
B |
$10.75 |
$4,300 |
I/I |
400 |
1,700 |
1.91 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP & Chief Medical Officer |
• – – |
2013-11-06 |
4 |
B |
$10.10 |
$5,050 |
I/I |
500 |
1,300 |
1.99 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP & Chief Medical Officer |
• – – |
2013-09-30 |
4 |
B |
$13.70 |
$877 |
I/I |
64 |
64 |
1.91 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP & Chief Medical Officer |
• – – |
2013-09-18 |
4 |
B |
$14.75 |
$11,800 |
I/I |
800 |
800 |
1.99 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
